Literature DB >> 20937446

Hypertension in special populations: chronic kidney disease, organ transplant recipients, pregnancy, autonomic dysfunction, racial and ethnic populations.

John M Flack1, Keith C Ferdinand, Samar A Nasser, Noreen F Rossi.   

Abstract

The benefits of appropriate blood pressure (BP) control include reductions in proteinuria and possibly a slowing of the progressive loss of kidney function. Overall, medication therapy to lower BP during pregnancy should be used mainly for maternal safety because of the lack of data to support an improvement in fetal outcome. The major goal of hypertension treatment in those with baroreceptor dysfunction is to avoid the precipitous, severe BP elevations that characteristically occur during emotional stimulation. The treatment of hypertension in African Americans optimally consists of comprehensive lifestyle modifications along with pharmacologic treatments, most often with combination, not single-drug, therapy.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937446     DOI: 10.1016/j.ccl.2010.07.007

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  3 in total

1.  Rosuvastatin beneficially alters the glomerular structure of kidneys from spontaneously hypertensive rats (SHRs).

Authors:  Erica Peres de Barros; Angélica Beatriz Garcia-Pinto; Priscilla Yório Machado; Mário José dos Santos Pereira; Jorge José de Carvalho
Journal:  J Mol Histol       Date:  2011-06-14       Impact factor: 2.611

2.  Low-Intensity physical activity beneficially alters the ultrastructural renal morphology of spontaneously hypertensive rats.

Authors:  Angélica Beatriz Garcia-Pinto; Verônica Soares de Matos; Vinicius Rocha; Jéssica Moraes-Teixeira; Jorge José Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  Pregnancy outcomes in liver and cardiothoracic transplant recipients: a UK national cohort study.

Authors:  Olaa Mohamed-Ahmed; Cathy Nelson-Piercy; Kate Bramham; Haiyan Gao; Jennifer J Kurinczuk; Peter Brocklehurst; Marian Knight
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.